| Dr Gregory Louis Kay, MD | |
|
2640 Benedict Canyon Dr, Beverly Hills, CA 90210-1023 | |
| (310) 278-2073 | |
| Not Available |
| Full Name | Dr Gregory Louis Kay |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 2640 Benedict Canyon Dr, Beverly Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881907707 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Louis Kay, MD 14431 Ventura Blvd, 215, Sherman Oaks, CA 91423-2606 Ph: () - | Dr Gregory Louis Kay, MD 2640 Benedict Canyon Dr, Beverly Hills, CA 90210-1023 Ph: (310) 278-2073 |
News Archive
The true power of genomic research lies in its ability to help scientists understand biological processes, particularly those that - when altered - can lead to disease. This power is demonstrated dramatically in a pair of papers published today in the journal Nature. In the first, a global team of researchers describes 95 different variations across the genome that contribute in different degrees to alterations in blood cholesterol and triglyceride levels in multiple human populations. In the second report, close examination of just one of these common variants not only reveals the involvement of an unexpected genetic pathway in lipid metabolism but also provides a blueprint for using genomic findings to unravel biological connections between lipid levels and coronary heart disease.
As the conference closed, Women Deliver President Jill Sheffield said advocates would address the economic dimensions of maternal mortality, the BBC reports. "Finance ministers are on our list - and they're not going to stay safe," she said. "They don't always see this as a critical issue. Our economic arguments for investing in women's health are pretty dramatic."
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19.
Researchers in RCSI (Royal College of Surgeons in Ireland) have conducted further in-depth research to predict how patients with bowel (colorectal) cancer will respond effectively to chemotherapy, to ensure that patients will get the most suitable type of treatment from the outset.
India's surge in SARS-CoV-2 infections are linked to the new variants B.1.617 and B.1.618, with mutated spike proteins.
› Verified 7 days ago
Mr. Ming N Huang, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 233 S Oakhurst Dr, Beverly Hills, CA 90212 Phone: 626-576-5465 |